LOS ANGELES, April 05, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Under Armour, Inc. (“Under Armour” or the “Company”) (NYSE:UA) (NYSE:UAA) concerning possible violations of federal securities laws between April 21, 2016 and January 30, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired the Company’s shares during the Class Period should contact the firm in advance of the April 10, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, Under Armour made materially false and misleading statements and/or failed to disclose that one of its largest wholesale retailers, The Sports Authority, was facing bankruptcy and as a result, Under Armour was at risk of not meeting its revenue and profit margins.
On January 30, 2017, the Company filed a Form 8-K wherein CEO Kevin Plank, noted that “numerous challenges and disruptions in North American retail tempered our [Company’s] fourth quarter results.” The Company also reported that its CFO was leaving the Company. When this information reached the public, the Company’s stock price decreased, thus harming investors.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
AFT Leaves X Over AI-Generated Images of Minors
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 



